SK9372000A3 - Substituted beta-alanines - Google Patents
Substituted beta-alanines Download PDFInfo
- Publication number
- SK9372000A3 SK9372000A3 SK937-2000A SK9372000A SK9372000A3 SK 9372000 A3 SK9372000 A3 SK 9372000A3 SK 9372000 A SK9372000 A SK 9372000A SK 9372000 A3 SK9372000 A3 SK 9372000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- compound
- group
- alkyl
- acetyl
- amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/42—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by carboxyl groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Indole Compounds (AREA)
- Polyamides (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Furan Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9727532.5A GB9727532D0 (en) | 1997-12-23 | 1997-12-23 | Chemical compounds |
US9260298P | 1998-07-13 | 1998-07-13 | |
PCT/GB1998/003859 WO1999033789A1 (fr) | 1997-12-23 | 1998-12-23 | β-ALANINES SUBSTITUEES |
Publications (1)
Publication Number | Publication Date |
---|---|
SK9372000A3 true SK9372000A3 (en) | 2002-03-05 |
Family
ID=26312873
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK937-2000A SK9372000A3 (en) | 1997-12-23 | 1998-12-23 | Substituted beta-alanines |
Country Status (19)
Country | Link |
---|---|
EP (1) | EP1042279B1 (fr) |
JP (1) | JP4555469B2 (fr) |
KR (1) | KR20010033520A (fr) |
CN (1) | CN1163477C (fr) |
AT (1) | ATE289991T1 (fr) |
AU (1) | AU747907B2 (fr) |
BR (1) | BR9814376A (fr) |
CA (1) | CA2316235A1 (fr) |
CZ (1) | CZ20002342A3 (fr) |
DE (1) | DE69829215T2 (fr) |
ES (1) | ES2235383T3 (fr) |
HK (1) | HK1034508A1 (fr) |
HU (1) | HUP0101701A3 (fr) |
IL (1) | IL136584A (fr) |
NO (1) | NO20003273D0 (fr) |
NZ (1) | NZ505363A (fr) |
SK (1) | SK9372000A3 (fr) |
TR (1) | TR200001947T2 (fr) |
WO (1) | WO1999033789A1 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0100336A3 (en) * | 1998-01-23 | 2002-11-28 | Novartis Ag | Vla-4 antagonists, pharmaceutical compositions comprising them and process for preparing them |
DE69937603T2 (de) * | 1998-12-23 | 2008-10-23 | Aventis Pharma Ltd., West Malling | Dihydro-benzo(1,4)oxazine und tetrahydro-quinoxaline |
CZ20012980A3 (cs) * | 1999-02-18 | 2002-04-17 | F. Hoffmann-La Roche Ag | Thioamidové deriváty |
IL149758A0 (en) | 1999-12-28 | 2002-11-10 | Pfizer Prod Inc | Non-peptidyl inhibitors of vla-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases |
DE10019755A1 (de) * | 2000-04-20 | 2001-11-08 | Bayer Ag | Neue Aminoaryl/cycloalkylcarbonsäuren als Integrinantagonisten |
FR2812633A1 (fr) * | 2000-08-04 | 2002-02-08 | Aventis Cropscience Sa | Derives de phenyl(thio)urees et phenyl(thio)carbamates fongicides |
GB2369357A (en) * | 2000-10-09 | 2002-05-29 | Bayer Ag | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
GB2367816A (en) | 2000-10-09 | 2002-04-17 | Bayer Ag | Urea- and thiourea-containing derivatives of beta-amino acids |
MXPA03003829A (es) * | 2000-11-04 | 2003-07-28 | Aventis Pharma Ltd | Acidos alcanoicos substituidos. |
RU2290403C2 (ru) | 2000-12-28 | 2006-12-27 | Дайити Фармасьютикал Ко., Лтд. | Ингибиторы vla-4 |
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
TWI340134B (en) | 2003-07-24 | 2011-04-11 | Daiichi Seiyaku Co | Cyclohexanecarboxylic acids |
WO2006116399A2 (fr) * | 2005-04-28 | 2006-11-02 | Ferring B.V. | Utilisation de nouveaux composes dans le traitement des maladies inflammatoires intestinales |
WO2007069635A1 (fr) | 2005-12-13 | 2007-06-21 | Daiichi Sankyo Company, Limited | Médicament inhibiteur de vla-4 |
EP2124996A4 (fr) | 2007-02-20 | 2010-03-24 | Merrimack Pharmaceuticals Inc | Méthodes de traitement de la sclérose en plaques par administration d'une alpha-foetoprotéine combinée à un antagoniste de l'intégrine |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6306840B1 (en) * | 1995-01-23 | 2001-10-23 | Biogen, Inc. | Cell adhesion inhibitors |
ES2161373T3 (es) * | 1995-08-30 | 2001-12-01 | Searle & Co | Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas. |
CA2250698A1 (fr) * | 1996-03-29 | 1997-10-09 | G.D. Searle & Co. | Derives d'acide phenylpropanoique para-substitues, utilises comme antagonistes de l'integrine |
AU2337097A (en) * | 1996-03-29 | 1997-10-22 | G.D. Searle & Co. | Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors |
TR200001179T2 (tr) * | 1997-10-31 | 2000-11-21 | Aventis Pharma Ltd. | Değiştirilmiş anilidler |
-
1998
- 1998-12-23 JP JP2000526473A patent/JP4555469B2/ja not_active Expired - Lifetime
- 1998-12-23 KR KR1020007007022A patent/KR20010033520A/ko not_active Ceased
- 1998-12-23 CN CNB988125005A patent/CN1163477C/zh not_active Expired - Fee Related
- 1998-12-23 BR BR9814376-0A patent/BR9814376A/pt not_active Application Discontinuation
- 1998-12-23 AT AT98962586T patent/ATE289991T1/de not_active IP Right Cessation
- 1998-12-23 WO PCT/GB1998/003859 patent/WO1999033789A1/fr active Search and Examination
- 1998-12-23 AU AU17719/99A patent/AU747907B2/en not_active Ceased
- 1998-12-23 NZ NZ505363A patent/NZ505363A/en unknown
- 1998-12-23 TR TR2000/01947T patent/TR200001947T2/xx unknown
- 1998-12-23 IL IL13658498A patent/IL136584A/xx not_active IP Right Cessation
- 1998-12-23 EP EP98962586A patent/EP1042279B1/fr not_active Expired - Lifetime
- 1998-12-23 SK SK937-2000A patent/SK9372000A3/sk unknown
- 1998-12-23 ES ES98962586T patent/ES2235383T3/es not_active Expired - Lifetime
- 1998-12-23 DE DE69829215T patent/DE69829215T2/de not_active Expired - Lifetime
- 1998-12-23 CZ CZ20002342A patent/CZ20002342A3/cs unknown
- 1998-12-23 HU HU0101701A patent/HUP0101701A3/hu unknown
- 1998-12-23 CA CA002316235A patent/CA2316235A1/fr not_active Abandoned
-
2000
- 2000-06-22 NO NO20003273A patent/NO20003273D0/no not_active Application Discontinuation
-
2001
- 2001-07-27 HK HK01105254A patent/HK1034508A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AU747907B2 (en) | 2002-05-30 |
TR200001947T2 (tr) | 2001-01-22 |
CN1283181A (zh) | 2001-02-07 |
EP1042279A1 (fr) | 2000-10-11 |
NZ505363A (en) | 2005-02-25 |
AU1771999A (en) | 1999-07-19 |
CN1163477C (zh) | 2004-08-25 |
NO20003273L (no) | 2000-06-22 |
WO1999033789A1 (fr) | 1999-07-08 |
EP1042279B1 (fr) | 2005-03-02 |
DE69829215D1 (de) | 2005-04-07 |
ATE289991T1 (de) | 2005-03-15 |
CZ20002342A3 (cs) | 2001-11-14 |
IL136584A (en) | 2005-03-20 |
BR9814376A (pt) | 2000-10-10 |
DE69829215T2 (de) | 2005-07-21 |
JP4555469B2 (ja) | 2010-09-29 |
HUP0101701A2 (hu) | 2001-11-28 |
IL136584A0 (en) | 2001-06-14 |
NO20003273D0 (no) | 2000-06-22 |
HK1034508A1 (en) | 2001-10-26 |
HUP0101701A3 (en) | 2003-02-28 |
KR20010033520A (ko) | 2001-04-25 |
CA2316235A1 (fr) | 1999-07-08 |
JP2001527061A (ja) | 2001-12-25 |
ES2235383T3 (es) | 2005-07-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK9372000A3 (en) | Substituted beta-alanines | |
EP1114028B1 (fr) | Bicycles aza modulant l'inhibition de l'adhesion cellulaire | |
EP1027328B1 (fr) | Anilides substituees | |
EP1183254B1 (fr) | Composes d'heteroaryle bicyclique substitue utilises comme antagonistes de l'integrine | |
EP1153017B1 (fr) | Composes bicycliques et leur utilisation comme ligands du recepteur de l'integrine | |
JP2001523711A (ja) | 細胞接着阻害薬としての環状アミノ酸誘導体 | |
EP1392306B1 (fr) | Tetrahydroisoquinolines substituees destinees au traitement des maladies inflammatoires | |
EP1177181B1 (fr) | Composes bicycliques substitues | |
WO1999054321A1 (fr) | Diamines substituees et leur utilisation en tant qu'inhibiteurs d'adhesion cellulaire | |
US6352977B1 (en) | Substituted β-alanines | |
JP3786203B2 (ja) | 置換アルカン酸 | |
US6762199B2 (en) | Indane derivatives | |
US6548533B2 (en) | Ureido substituted pyrrolidines | |
ES2297943T3 (es) | Dihidro-benzo(1,4)oxacinas y tetrahidroquinoxalinas. | |
MXPA00006218A (en) | SUBSTITUTED&bgr;-ALANINES | |
JP4856314B2 (ja) | 置換ピロリジン |